lactitol has been researched along with Chagas Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alzari, PM; Chen, Z; Crennell, SJ; Frasch, AC; Marcé, P; Resende, R; van den Elsen, JMH; Watts, AG | 1 |
| Agustí, R; de Lederkremer, RM; Frasch, AC; París, G; Ratier, L | 1 |
2 other study(ies) available for lactitol and Chagas Disease
| Article | Year |
|---|---|
The synthesis and kinetic evaluation of aryl α-aminophosphonates as novel inhibitors of T. cruzi trans-sialidase.
Topics: Amination; Chagas Disease; Enzyme Inhibitors; Glycoproteins; Humans; Molecular Docking Simulation; Neuraminidase; Organophosphonates; Trypanocidal Agents; Trypanosoma cruzi | 2018 |
Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
Topics: Animals; Binding Sites; Chagas Disease; Chlorocebus aethiops; Enzyme Inhibitors; Glycoproteins; Neuraminidase; Protein Binding; Protein Structure, Tertiary; Sialic Acids; Substrate Specificity; Sugar Alcohols; Trypanosoma cruzi; Vero Cells; Virulence | 2004 |